Harry Kleanthous
Corporate Officer/Principal presso SK BIOSCIENCE CO.,LTD.
Posizioni attive di Harry Kleanthous
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SK BIOSCIENCE CO.,LTD. | Corporate Officer/Principal | 21/10/2022 | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - | - |
Storia della carriera di Harry Kleanthous
Formazione di Harry Kleanthous
| University of London | Doctorate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Corea del Sud | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SK BIOSCIENCE CO.,LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
- Borsa valori
- Insiders
- Harry Kleanthous
- Esperienza
